122 related articles for article (PubMed ID: 17199160)
1. Intravitreal Bioerudivel sustained-release triamcinolone microspheres system (RETAAC). Preliminary report of its potential usefulnes for the treatment of diabetic macular edema.
Cardillo JA; Souza-Filho AA; Oliveira AG
Arch Soc Esp Oftalmol; 2006 Dec; 81(12):675-7, 679-81. PubMed ID: 17199160
[No Abstract] [Full Text] [Related]
2. Diabetic macular edema: towards therapy aimed at the underlying pathogenic mechanisms.
Averbukh E; Banin E
Isr Med Assoc J; 2006 Feb; 8(2):127-8. PubMed ID: 16544738
[No Abstract] [Full Text] [Related]
3. Intravitreal preservative-free triamcinolone acetonide for the treatment of macular oedema.
Bakri SJ; Shah A; Falk NS; Beer PM
Eye (Lond); 2005 Jun; 19(6):686-8. PubMed ID: 15332099
[TBL] [Abstract][Full Text] [Related]
4. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone injection for diffuse diabetic macular edema with foveal cystoid changes.
Barak A; Regenbogen M; Goldstein M; Loewenstein A
Isr Med Assoc J; 2006 Feb; 8(2):83-7. PubMed ID: 16544727
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone acetonide in Eales' disease: a case report.
Pathengay A; Pilli S; Das T
Eye (Lond); 2005 Jun; 19(6):711-3. PubMed ID: 15332094
[No Abstract] [Full Text] [Related]
7. [Macular oedema and intravitreal triamcinolone injections].
Gunnlaugsdóttir E; Oehman DO; Gunnarsdóttir SG; Stefánsson E
Laeknabladid; 2006 Dec; 92(12):847-57. PubMed ID: 17206015
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
Jonas JB; Kreissig I; Degenring RF
Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal triamcinolone as a primary therapy in diabetic macular oedema.
Ziahosseini K; Fong KC; Horgan SE
Eye (Lond); 2006 Jul; 20(7):861-2; author reply 862-3. PubMed ID: 16096662
[No Abstract] [Full Text] [Related]
10. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I
Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306
[TBL] [Abstract][Full Text] [Related]
11. Outcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema.
Konstantopoulos A; Williams CP; Luff AJ
Eye (Lond); 2008 Feb; 22(2):219-22. PubMed ID: 17016463
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
13. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
[TBL] [Abstract][Full Text] [Related]
14. [Current therapeutic approach to diabetic macular edema refractory to laser coagulation].
Davidescu L; Baltă F; Mocanu C; Puşcaşu CR; Olaru A
Oftalmologia; 2010; 54(2):91-8. PubMed ID: 20827918
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.
Massin P; Audren F; Haouchine B; Erginay A; Bergmann JF; Benosman R; Caulin C; Gaudric A
Ophthalmology; 2004 Feb; 111(2):218-24; discussion 224-5. PubMed ID: 15019365
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone.
Stefánsson E
Ophthalmology; 2007 Aug; 114(8):1590; author reply 1590. PubMed ID: 17678704
[No Abstract] [Full Text] [Related]
17. Update on treatments for diabetic macular edema.
Fraser-Bell S; Kaines A; Hykin PG
Curr Opin Ophthalmol; 2008 May; 19(3):185-9. PubMed ID: 18408491
[TBL] [Abstract][Full Text] [Related]
18. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
[TBL] [Abstract][Full Text] [Related]
19. Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion.
Degenring RF; Kamppeter B; Kreissig I; Jonas JB
Acta Ophthalmol Scand; 2003 Oct; 81(5):548-50. PubMed ID: 14510813
[No Abstract] [Full Text] [Related]
20. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Bobbili RB; Mathai A
Am J Ophthalmol; 2006 Sep; 142(3):531; author reply 531-2. PubMed ID: 16935620
[No Abstract] [Full Text] [Related]
[Next] [New Search]
